Boston Scientific Current Ratio 2006-2019 | BSX

Current and historical current ratio for Boston Scientific (BSX) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Boston Scientific current ratio for the three months ending June 30, 2019 was 1.31.
Boston Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $6.33B $4.85B 1.31
2019-03-31 $6.23B $4.48B 1.39
2018-12-31 $4.00B $5.26B 0.76
2018-09-30 $3.97B $5.08B 0.78
2018-06-30 $3.93B $4.75B 0.83
2018-03-31 $4.08B $4.99B 0.82
2017-12-31 $3.82B $5.65B 0.68
2017-09-30 $3.48B $4.83B 0.72
2017-06-30 $3.22B $4.30B 0.75
2017-03-31 $3.03B $3.49B 0.87
2016-12-31 $3.24B $3.59B 0.90
2016-09-30 $3.18B $3.02B 1.06
2016-06-30 $3.33B $3.18B 1.05
2016-03-31 $3.16B $2.61B 1.21
2015-12-31 $3.47B $2.43B 1.43
2015-09-30 $3.46B $2.24B 1.55
2015-06-30 $3.77B $1.94B 1.95
2015-03-31 $3.19B $2.46B 1.30
2014-12-31 $3.61B $2.85B 1.27
2014-09-30 $3.18B $1.82B 1.75
2014-06-30 $3.21B $1.77B 1.81
2014-03-31 $2.94B $1.72B 1.71
2013-12-31 $3.01B $1.82B 1.65
2013-09-30 $3.53B $1.90B 1.85
2013-06-30 $3.50B $2.48B 1.41
2013-03-31 $3.10B $1.64B 1.90
2012-12-31 $3.02B $1.77B 1.71
2012-09-30 $3.17B $1.82B 1.75
2012-06-30 $3.11B $1.79B 1.73
2012-03-31 $3.09B $1.67B 1.85
2011-12-31 $3.11B $1.81B 1.72
2011-09-30 $3.21B $1.89B 1.70
2011-06-30 $3.15B $1.89B 1.66
2011-03-31 $3.57B $2.04B 1.75
2010-12-31 $3.62B $2.61B 1.39
2010-09-30 $3.56B $2.96B 1.20
2010-06-30 $3.99B $3.72B 1.07
2010-03-31 $3.75B $2.91B 1.29
2009-12-31 $4.60B $3.02B 1.52
2009-09-30 $4.96B $3.18B 1.56
2009-06-30 $4.80B $2.75B 1.74
2009-03-31 $4.57B $2.43B 1.88
2008-12-31 $5.45B $3.23B 1.69
2008-09-30 $5.29B $3.54B 1.49
2008-06-30 $5.17B $3.04B 1.70
2008-03-31 $5.24B $3.39B 1.55
2007-12-31 $5.94B $3.25B 1.83
2007-09-30 $4.69B $3.38B 1.39
2007-06-30 $4.94B $2.97B 1.66
2007-03-31 $4.58B $2.37B 1.93
2006-12-31 $6.03B $2.63B 2.29
2006-09-30 $4.75B $2.45B 1.94
2006-06-30 $4.41B $2.17B 2.03
2006-03-31 $2.87B $2.04B 1.41
2005-12-31 $2.63B $1.48B 1.78
2005-09-30 $2.76B $1.14B 2.42
2005-06-30 $2.72B $1.76B 1.55
2005-03-31 $2.76B $1.78B 1.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $58.240B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
United-Guardian (UG) United States $0.088B 20.72
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00